Filing Flows

Filing Flows › DexCom (DXCM) › Next earnings date

DexCom (DXCM) earnings: beat the estimate

DexCom (DXCM) reported on Oct 29, 2026 and beat the EPS estimate: $0.73 against $0.67 (+8.3%). Revenue was $1.3B for Q3 2026, +11% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+8.3% vs estimate
Beat rate100%

The last report

DexCom reported revenue of $1.3B for the third quarter 2026 (+11% Y/Y), net earnings $275M. How it makes money → · Every quarter →

DexCom: EPS against the estimate, last 5 reportsDexCom: EPS against the estimate, last 5 reportsEstimateReported$0.57$0.61Oct 25$0.65$0.68Feb 26$0.47$0.56Apr 26$0.61$0.70Jul 26$0.67$0.73Oct 26
Latest (Oct 26): Estimate $0.67, Reported $0.73.
DXCM: the stock's move on each reportDXCM: the stock's move on each reportJul 30, 2026+11.1%Apr 30, 2026+6.6%Feb 12, 2026+2.7%Oct 30, 2025-14.6%

DexCom's latest quarter

DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.

Questions

Did DexCom beat earnings?

DexCom (DXCM) reported on Oct 29, 2026 and beat the EPS estimate: $0.73 against $0.67 (+8.3%).

When does DXCM report earnings?

The next date is not set yet.

Does DexCom usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.